Scinovex
articleTop 1% cited

Microvesicles derived from human adult mesenchymal stem cells protect against ischaemia-reperfusion-induced acute and chronic kidney injury

Nephrology Dialysis Transplantation · 2011 · Vol. 26(5) · pp. 1474–1483
Stefano GattiStefania BrunoMaria Chiara DeregibusAndrea SordiVincenzo CantaluppiCiro TettaGiovanni Camussi

Abstract

MVs released from MSCs protect from AKI induced by ischaemia reperfusion injury and from subsequent chronic renal damage. This suggest that MVs could be exploited as a potential new therapeutic approach.

Extracellular vesicles in diseaseMesenchymal stem cell researchMicroRNA in disease regulationMedicineMicrovesiclesParacrine signallingMesenchymal stem cellAcute kidney injuryKidneyIschemiaRenal stem cellReperfusion injuryKidney disease

MeSH terms

AdultAnimalsCell DifferentiationCells, CulturedHumansKidney Failure, ChronicKidney TubulesMaleReperfusion InjuryRats, Sprague-DawleyMesenchymal Stem Cell TransplantationCell ProliferationRatsCell-Derived MicroparticlesAcute Kidney Injury
Citations
806
FWCI
20.09
field-weighted impact
References
48
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.